We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Observational analysis reports outcomes of concurrent radiotherapy with tarlatamab in extensive-stage small cell lung cancer, suggesting improved management options.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: